Absci Corporation

Last updated September 27, 2026

Organization details

Legal name
Absci Corporation
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
ABSI
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001672688

Board of directors

Chief executives

Sean McClain · Chief Executive Officer
Dates unknown

Board connections

4 of this board's directors also sit on 9 other boards.

Network of Absci Corporation's board connections Alphatec Holdings Inc. Alphatec Holdings Inc. Atara Biotherapeutics Inc. Atara Biotherapeutics... Averin Capital Acquisition Corp. Averin Capital Acquisi... Biogen Inc. Biogen Inc. Fate Therapeutics Inc. Fate Therapeutics Inc. Kura Oncology Inc. Kura Oncology Inc. Shattuck Labs Inc. Shattuck Labs Inc. TriSalus Life Sciences Inc. TriSalus Life Sciences... iRhythm Holdings Inc. iRhythm Holdings Inc. Jeremy Green Jeremy Green Karen K. Mcginnis Karen K. Mcginnis Mary T. Szela Mary T. Szela Menelas N. Pangalos Menelas N. Pangalos Absci Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$933,174
5 purchases by 4 insiders
Sold, last 12 months
$132,328
2 sales by 2 insiders
Date Insider Transaction Shares Price Value
Aug 31, 2026 Zachariah Jonasson Officer (CFO / CBO) Shares withheld for tax −8,320 $8.71 $72,467
Jun 30, 2026 Mary T. Szela Director Open-market purchase +12,900 $11.54 $148,866
Jun 24, 2026 Sean McClain Director, Officer (Chief Executive Officer) Shares withheld for tax −59,896 $10.08 $603,752
Jun 4, 2026 Karen K. Mcginnis Director Grant or award +10,100 — —
Jun 4, 2026 Mary T. Szela Director Grant or award +10,100 — —
Jun 4, 2026 Menelas N. Pangalos Director Grant or award +10,100 — —
Jun 4, 2026 Houten Frans Van Director Grant or award +10,100 — —
Jun 4, 2026 Daniel A. Rabinovitsj Director Grant or award +10,100 — —
Jun 4, 2026 Joseph Sirosh Director Grant or award +10,100 — —
May 31, 2026 Zachariah Jonasson Officer (CFO / CBO) Shares withheld for tax −8,319 $6.75 $56,153
May 13, 2026 Menelas N. Pangalos Director Open-market purchase +37,453 $5.36 $200,748
Mar 12, 2026 Busch Andreas Officer (Chief Innovation Officer) Open-market purchase +100,000 $2.29 $229,000
Mar 3, 2026 Busch Andreas Officer (Chief Innovation Officer) Shares withheld for tax −1,257 $2.80 $3,520
Mar 3, 2026 Walker Shelby J. Officer (Chief Legal Officer) Shares withheld for tax −9,825 $2.80 $27,510
Mar 3, 2026 Sean McClain Director, Officer (Chief Executive Officer) Shares withheld for tax −25,316 $2.80 $70,885

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.